127 related articles for article (PubMed ID: 5136070)
1. Low molecular weight dextran and matching by enzyme technics.
Murray S; Dewar PJ
Transfusion; 1971; 11(6):378-81. PubMed ID: 5136070
[No Abstract] [Full Text] [Related]
2. [Undesirable effects of macromolecules].
Hint H
Anesth Analg (Paris); 1976; 3(4):703-7. PubMed ID: 1015656
[No Abstract] [Full Text] [Related]
3. Dextran--plasma volume expanders clinical experiences especially with low molecular weight preparations.
Arturson G
Bibl Haematol; 1968; 29():914-26. PubMed ID: 5728135
[No Abstract] [Full Text] [Related]
4. The influence of plasma substitutes on the suspension stability of human blood.
Heeres SG; Zijlstra WG
Bibl Haematol; 1968; 29():1167-71. PubMed ID: 5700313
[No Abstract] [Full Text] [Related]
5. Anaphylactic reactions to high molecular weight dextran during hysteroscopic surgery.
Huhn AM
CRNA; 1995 Nov; 6(4):167-71. PubMed ID: 8680345
[TBL] [Abstract][Full Text] [Related]
6. Incidence and severity of anaphylactoid reactions to colloid volume substitutes.
Ring J; Messmer K
Lancet; 1977 Feb; 1(8009):466-9. PubMed ID: 65572
[TBL] [Abstract][Full Text] [Related]
7. The influence of dextran on the sedimentation behavior of human red cells: macro and micro studies.
Meiselman HJ
Bibl Anat; 1969; 10():20-31. PubMed ID: 5407364
[No Abstract] [Full Text] [Related]
8. Some effects of dextran on human erythrocyte interactions.
Brooks DE; Seaman GV
Bibl Anat; 1973; 11():272-80. PubMed ID: 4789051
[No Abstract] [Full Text] [Related]
9. Nonspecific warm hemolysins of papain-treated cells: serologic characterization and transfusion risk.
Bell CA; Zwicker H; Nevius DB
Transfusion; 1973; 13(4):207-13. PubMed ID: 4198437
[No Abstract] [Full Text] [Related]
10. Comparison of rheological effects of isoviscous concentrations of dextran 40 and 150 upon erythrocyte aggregation and cell viscosity.
Bygdeman S; Wells R
Bibl Anat; 1969; 10():16-9. PubMed ID: 5407357
[No Abstract] [Full Text] [Related]
11. [Death caused by infusion of low-molecular dextran].
Plamieniak L; Kowal-Gierczak B; Kotschy M; Kurzawska M; Kozlowska B
Wiad Lek; 1974 May; 27(10):901-5. PubMed ID: 4839858
[No Abstract] [Full Text] [Related]
12. [Pathogenesis of hemostasis disorders due to infusions].
Perlick E
Z Gesamte Inn Med; 1970 Aug; 25(15):666-71. PubMed ID: 5527529
[No Abstract] [Full Text] [Related]
13. Low-molecular dextran in chronic circulatory failure. Effect estimated by lung diffusing capacity.
Solvsteen P; Nathan E
Acta Med Scand; 1968; 184(1-2):79-82. PubMed ID: 5703966
[No Abstract] [Full Text] [Related]
14. Rheological studies on the kinetics of artificial red cell aggregation induced by dextrans.
Volger E; Schmid-Schönbein H; Klose HJ
Bibl Anat; 1973; 11():83-90. PubMed ID: 4789095
[No Abstract] [Full Text] [Related]
15. Effects of dextran molecular weight on red blood cell aggregation.
Neu B; Wenby R; Meiselman HJ
Biophys J; 2008 Sep; 95(6):3059-65. PubMed ID: 18586848
[TBL] [Abstract][Full Text] [Related]
16. Intermittent low molecular weight dextran infusions in the management of ischemic skin disorders.
Holti G
Bibl Anat; 1973; 11():359-63. PubMed ID: 4789063
[No Abstract] [Full Text] [Related]
17. Red cell aggregation by macromolecules: roles of surface adsorption and electrostatic repulsion.
Chien S; Jan KM
J Supramol Struct; 1973; 1(4):385-409. PubMed ID: 4358445
[No Abstract] [Full Text] [Related]
18. Human granulocyte function during dextran infusion.
Jarstrand C; Lahnborg G; Berghem L
Acta Chir Scand Suppl; 1979; 489():279-86. PubMed ID: 291264
[TBL] [Abstract][Full Text] [Related]
19. [On a case of incompatibility to dextran during general anesthesia].
Simone M
Acta Anaesthesiol; 1965; 16(4):555-63. PubMed ID: 4158693
[No Abstract] [Full Text] [Related]
20. An assessment of the potential use of anionic dextrans as a plasma substitute.
Chang RL; Crawford MP; West MD
J Biomed Eng; 1980 Jan; 2(1):41-4. PubMed ID: 7359897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
